[HTML][HTML] The EUTOS prognostic score: review and validation in 1288 patients with CML treated frontline with imatinib
…, W Prejzner, JL Steegmann, J Mayer, K Indrak…�- Leukemia, 2013 - nature.com
The introduction of tyrosine kinase inhibitors (TKI) in the treatment of Philadelphia
chromosome-positive (Ph+) chronic myeloid leukemia (CML) has revolutionized the outcome, but the …
chromosome-positive (Ph+) chronic myeloid leukemia (CML) has revolutionized the outcome, but the …
A 1-tb 4b/cell 4-plane 162-layer 3D flash memory with a 2.4-Gb/s I/O speed interface
…, A Matsuda, C Puri, C Chen, KV Indra…�- …�Solid-State Circuits�…, 2022 - ieeexplore.ieee.org
The presented 1Tb 4b/cell 162 WL layer 3D Flash memory achieves an areal density of 15
Gb/mm 2 which is 8.7% higher than prior work [1]. High-performance is the key enabler for 4b/…
Gb/mm 2 which is 8.7% higher than prior work [1]. High-performance is the key enabler for 4b/…
The EUTOS population-based registry: incidence and clinical characteristics of 2904 CML patients in 20 European Countries
…, S Burgstaller, D Sertic, P Costeas, J Mayer, K Indrak…�- Leukemia, 2015 - nature.com
This population-based registry was designed to provide robust and updated information on
the characteristics and the epidemiology of chronic myeloid leukemia (CML). All cases of …
the characteristics and the epidemiology of chronic myeloid leukemia (CML). All cases of …
Identification of a human mutation of DMT1 in a patient with microcytic anemia and iron overload
…, Y Guan, D Pospisilova, M Priwitzerova, K Indrak…�- Blood, 2005 - ashpublications.org
Divalent metal transporter 1 (DMT1) is a transmembrane protein crucial for duodenal iron
absorption and erythroid iron transport. DMT1 function has been elucidated largely in studies …
absorption and erythroid iron transport. DMT1 function has been elucidated largely in studies …
[PDF][PDF] Saliva as a diagnostic medium.
…, E Faber, P Michl, J Pazdera, K Indrak�- Biomedical Papers of�…, 2009 - academia.edu
Background: This is a review of current knowledge on the use of saliva, gingival cervical
fluid and mucosal transudate in the detection of some oral and systemic diseases as well as …
fluid and mucosal transudate in the detection of some oral and systemic diseases as well as …
High-dose therapy and autologous stem-cell transplantation in Waldenstr�m macroglobulinemia: the Lymphoma Working Party of the European Group for Blood and�…
…, W Arcese, K Kolbe, NC Gorin, K Thomson…�- Journal of clinical�…, 2010 - ascopubs.org
Purpose The role of autologous stem-cell transplantation (ASCT) in Waldenstr�m
macroglobulinemia (WM) is not defined. The aim of this study was to analyze the results of ASCT in …
macroglobulinemia (WM) is not defined. The aim of this study was to analyze the results of ASCT in …
Treatment and outcome of 2904 CML patients from the EUTOS population-based registry
…, A Zaritskey, M H�glund, B Simonsson, K Indrak…�- Leukemia, 2017 - nature.com
The European Treatment and Outcome Study (EUTOS) population-based registry includes
data of all adult patients newly diagnosed with Philadelphia chromosome-positive and/or …
data of all adult patients newly diagnosed with Philadelphia chromosome-positive and/or …
[PDF][PDF] Secondary acute myeloid leukemia—a single center experience
…, J Zapletalov�, K Sicova, J Hubacek, K Indrak�- Neoplasma, 2010 - researchgate.net
Over that period of time, a total 574 patients with AML were diagnosed. Of those, 430
patients were diagnosed as having primary AML; in 86 patients, sAML transformed from …
patients were diagnosed as having primary AML; in 86 patients, sAML transformed from …
Two new EPO receptor mutations: truncated EPO receptors are most frequently associated with primary familial and congenital polycythemias
R Kralovics, K Indrak, T Stopka…�- Blood, The Journal�…, 1997 - ashpublications.org
Primary polycythemias are caused by an acquired or inborn mutation affecting
hematopoietic/erythroid progenitors that results in an abnormal response to hematopoietic cytokines. …
hematopoietic/erythroid progenitors that results in an abnormal response to hematopoietic cytokines. …
The electronics of the INDRA 4π detection array
J Pouthas, A Bertaut, B Borderie, P Bourgault…�- Nuclear Instruments and�…, 1996 - Elsevier
… INDRA is a 4"rr detection array designed for the studies of "hot nuclei" at the heavy ion
accelerator GANIL. The INDRA multidetector is composed of 96 ionization chambers, 196 silicon …
accelerator GANIL. The INDRA multidetector is composed of 96 ionization chambers, 196 silicon …